Feasibility of convection‐enhanced delivery of unlabeled 225Ac for glioblastoma: Transport, dosimetry, and clonogenic survival modeling
Maram El Sabri, Leyla Moghaddasi, Puthenparampil Wilson, Frank Saran, Eva Bezak · 2026
Read Feasibility of convection‐enhanced delivery of unlabeled 225Ac for glioblastoma: Transport, dosimetry, and clonogenic survival modeling by Maram El Sabri, Leyla Moghaddasi, Puthenparampil Wilson, Frank Saran, Eva Bezak (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13389104.txt.
Description
Maram El Sabri and co-authors model a way to deliver the radioactive isotope actinium-225 directly into glioblastoma tumours using pressure-driven flow. This brain cancer recurs locally in over ninety percent of cases because surgery, radiation, and chemotherapy leave resistant cells behind. Alpha particles from actinium-225 kill powerfully but travel only a short distance, so delivery matters.
Their computer model combines diffusion, bulk flow, and the full radioactive decay chain in a simplified brain geometry, then converts the resulting doses into predicted cell survival. Convection-enhanced delivery reached therapeutic doses about 1.43 centimetres from injection points. A five-injection plan totalling ten megabecquerels cut the surviving fraction of tumour cells from one hundred percent to roughly 3.4 percent in the model, with higher activities reducing it further. The authors present the work as a feasibility study of both the promise and the limits of this approach.
Catalog record
| CREATOR | Maram El Sabri, Leyla Moghaddasi, Puthenparampil Wilson, Frank Saran, Eva Bezak |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |